Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A major new Lancet Commission has called for people taking psychiatric medications - such as antidepressants, antipsychotics, and mood stabilisers - to receive proactive, ongoing physical health monitoring and support.

A close up of the hands of a doctor wearing a stethoscope filling out a medical form © Shutterstock

The Commission, co-led by experts from the University of Oxford's Department of Psychiatry, King’s College London, and the University of Queensland, Australia, sets out practical recommendations for clinicians to manage the physical side effects of psychiatric drugs while preserving their mental health benefits.

Psychiatric medications are essential in the treatment of conditions such as depression, bipolar disorder, and schizophrenia. However, these drugs can cause significant physical side effects - including weight gain, high blood pressure, diabetes, and raised cholesterol. These complications are often under-recognised and under-treated in routine care. If left unaddressed, these side effects can reduce quality of life, increase risk of long-term physical illness, and may lead some individuals to stop taking medications that are otherwise effective for their mental health.

The Commission systematically reviewed the available evidence across 11 major domains of side effects, including metabolic, cardiovascular, renal, sexual, and neurological complications. In response, it proposes a set of core monitoring and management strategies, beginning with a comprehensive physical health assessment at the point of prescribing, followed by early monitoring (e.g., weight checks within four weeks), and long-term follow-up of cardiometabolic markers such as blood sugars, cholesterol, and blood pressure.

 

Read the full story on the Department of Psychiatry website.